SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TELK -- Telik, Inc. -- Ignore unavailable to you. Want to Upgrade?


To: keokalani'nui who wrote (873)6/13/2007 9:27:43 PM
From: software salesperson  Read Replies (1) | Respond to of 887
 
secinfo.com

The Company ’s executive officers are appointed by the Board of Directors and serve until their successors are elected or appointed. There are no family relationships among any of the Company ’s directors or executive officers. Dr. Brown, one of the Company ’s key personnel, is the spouse of Dr. Wick, the Company ’s President, Chief Executive Officer and Chairman. No director has a contractual right to serve as a member of the Company ’s Board of Directors.



To: keokalani'nui who wrote (873)6/14/2007 1:06:52 AM
From: Icebrg  Respond to of 887
 
>>Was it ever pointed out by telk that the CMO and CEO were married? I don't recall it. >>

It has been mentioned "on the boards", but I can't say I have seen anything official from the company on the subject.

Compared with the Drakemans, Wick handled the family ties poorly. He should have spun off some of the more promising compounds to a new company and put his wife in charge. In that way, they would have limited the one-basket-risks. But maybe there were no promising compounds available for the spin.

Erik



To: keokalani'nui who wrote (873)6/14/2007 1:16:49 AM
From: former_pgs  Respond to of 887
 
If I recall correctly, it was noted on the Form 4s that have been filed by the company on behalf of Wick or his wife.



To: keokalani'nui who wrote (873)6/16/2007 8:11:22 PM
From: keokalani'nui  Read Replies (1) | Respond to of 887
 
<this may work out after all...but I am hoping things are actually bad enough there will be a thorough housecleaning and big sign in the window.>

FDA Converts TELCYTA Full Clinical Hold to Partial Hold
Friday June 15, 9:42 pm ET

PALO ALTO, Calif., June 15 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK - News) announced that the U.S. Food and Drug Administration (FDA) has converted the recently announced full clinical hold of TELCYTA trials to a partial hold. This action will enable patients currently enrolled in the ASSIST-3 and ASSIST-5 trials the opportunity to continue to receive study treatments, including TELCYTA in combination with chemotherapy, subject to re-consenting procedures. Telik continues to work closely with the FDA in its review of TELCYTA.